UAMS Performs Groundbreaking Epilepsy Surgery as Part of FDA-Approved Clinical Trial
June 16, 2025 | LITTLE ROCK — Surgeons from the University of Arkansas for Medical Sciences (UAMS) have performed the first transplantation in Arkansas of interneuron cell therapy, called NRTX-1001, into a patient with non-lesional epilepsy as part of an FDA-approved clinical trial under way at multiple locations across the United States. Four months later, the 33-year-old patient, who...